Skip to content

The psychological and economic impact of endometriosis

The psychological and economic impact of endometriosis

The psychological and economic impact of endometriosis

The psychological and economic impact of endometriosis

We’re thrilled to present the third episode of Scailyte’s Endometriosis Awareness Series, where Cinzia Donato interviews Dr. Alina Staikov on “The psychological and economic impact of endometriosis”.

Dr. Staikov is a specialized gynecologist with a wealth of experience in the field. She completed her medical studies at the University of Sofia and specialized in gynecology and obstetrics at the Ruppiner Kliniken, an educational hospital of Charité in Berlin. Her passion for women’s health led her to establish gynecological and obstetrical consulting at the Center for Integrative Medicine in Zurich and work as a senior specialist at Seespital Horgen. Dr. Staikov is also certified in educational programs in gynecology and obstetrics.

In 2019, Dr. Staikov founded Gynpoint, a gynecology and obstetrics practice with locations in Zurich and Horgen, where she offers the whole spectrum of modern diagnostics and therapeutics. With over 7000 patients consulted each year, she has gained invaluable insights into the challenges faced by women with endometriosis.

Dr. Staikov plays an essential role in raising awareness of endometriosis as a collaborator with the Endometriosevereinigung-Schweiz. Her dedication to educating and supporting patients is commendable, and we’re honored to have her share her expertise in our interview.

Join us as we delve into endometriosis awareness among different age groups, the benefits of early diagnosis and the psychological and economic impact of endometriosis with Dr. Alina Staikov. Gain valuable insights into this complex condition and its far-reaching effects on women’s lives.

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...

Read more

Recent News

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...

Read more

Recent News

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...

Read more

Recent News

Genomics for Health 2024

Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...

Read more

Recent News

The Year of the AI Nobel

2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...

Read more

Recent News

Life Science Industry Meets Data Science Symposium

Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...

Read more

Recent News

World CB & CDx Summit 2024

Scailyte is thrilled to attend Hanson Wade's 14th World CB & CDx Summit - the flagship CDx event of ...

Read more

Recent News

01 /04

Precision Medicine and The Future of Genomics Summit 2024

Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...

Read more

Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution

In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...

Read more

Recent News

02 /04

Pitch Nic 2024 at Novartis Campus

We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...

Read more

Recent News

03 /04

Genomics for Health 2024

Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...

Read more

The Year of the AI Nobel

2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...

Read more

Recent News

04 /04

Life Science Industry Meets Data Science Symposium

Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...

Read more

World CB & CDx Summit 2024

Scailyte is thrilled to attend Hanson Wade's 14th World CB & CDx Summit - the flagship CDx event of ...

Read more

Recent News